VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 49 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,556 | -56.9% | 16,874 | -27.9% | 0.00% | -100.0% |
| Q1 2023 | $152,087 | +322.5% | 23,398 | +24.4% | 0.00% | – |
| Q2 2022 | $36,000 | -92.2% | 18,808 | -55.2% | 0.00% | -100.0% |
| Q1 2020 | $459,000 | -44.6% | 41,973 | -19.4% | 0.01% | +140.0% |
| Q4 2019 | $828,000 | – | 52,093 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,410,412 | $55,419,000 | 1.48% |
| Asymmetry Capital Management, L.P. | 76,885 | $1,249,000 | 1.15% |
| Fosun International Ltd | 794,279 | $12,907,000 | 0.62% |
| Orbimed Advisors | 1,479,733 | $24,046,000 | 0.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 117,000 | $1,901,000 | 0.22% |
| Capital Investment Advisory Services, LLC | 10,700 | $174,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 20,000 | $325,000 | 0.07% |
| CONNING INC. | 129,013 | $2,096,000 | 0.06% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 215,145 | $3,496,000 | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 34,812 | $566,000 | 0.03% |